PMU13 Schizophrenia treatment with second-generation antipsychotics: a MULTI-country evaluation of the costs of cardiovascular and metabolic adverse events and weight gain

Kearns, B., Cooper, K. orcid.org/0000-0002-7702-8103 and Cantrell, A. orcid.org/0000-0003-0040-9853 (2020) PMU13 Schizophrenia treatment with second-generation antipsychotics: a MULTI-country evaluation of the costs of cardiovascular and metabolic adverse events and weight gain. In: Value in Health. Virtual ISPOR Europe 2020, 16-19 Nov 2020, Online. Elsevier , S605-S605.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2020 Elsevier. This is an author produced version of a paper subsequently published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Poster: © 2020 The Author(s). For reuse permissions, please contact the Author(s).
Dates:
  • Published: December 2020
  • Published (online): 11 December 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 09 Aug 2024 12:03
Last Modified: 09 Aug 2024 12:03
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: 10.1016/j.jval.2020.08.1225
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)